NCT04229927 - BPDO-1603 Intervention Trial in Patients With Moderate-to-severe Alzheimer's Disease | Biotech Hunter

Enrollment

712

Participants

Timeline

Start Date

February 27, 2020

Primary Completion Date

February 28, 2022

Study Completion Date

March 1, 2023

Conditions

Moderate-to-severe Alzheimer's Disease

Interventions

DRUG

BPDO-1603

"Arm1 : 1 tablet of the test drug, and 1 tablet of placebo reference drug~Arm2 : 1 tablet of the reference drug, and 1 tablet of placebo test drug"

Trial Locations (1)

RECRUITING

Inha University Hospital, Incheon